All Professionals
Overview
Benjamin Stein is a Boston-based corporate partner at Paul Hastings. He advises privately held and publicly traded companies across the company life cycle, including formation and founder matters, venture capital and growth-stage financings, buy- and sell-side mergers and acquisitions, initial public offerings, SEC-registered offerings, SEC compliance and corporate governance.
In addition, Ben represents venture capital, private equity firms and large strategic institutions in connection with their investments in emerging growth and later-stage companies and M&A transactions.
Ben represents clients across several industries, with a focus on the life sciences, technology and sports industries.
Accolades
- Rising Star, New England Legal Awards (2025)
- M&A Atlas Awards, Americas Rising Star Dealmaker (2024)
- The M&A Advisor, Emerging Leader (2024)
- The Legal 500 US, Recommended Lawyer, M&A/Corporate & Commercial: M&A: Large Deals ($1bn+) (2024)
- The Legal 500 UK, Recommended Lawyer, Finance: Debt Capital Markets (2021)
Education
- University of San Diego School of Law, J.D., 2011, concentration in Business and Corporate law
- University of New Hampshire, B.A., 2008, Economics
Representations
Life Sciences Representations and Transactions
- Ankyra Therapeutics, a biotechnology company, in general corporate matters, including in its expanded collaboration with Johnson & Johnson to advance the clinical development of a drug conjugate that is in Phase 1 clinical trials for solid tumors
- Care Access Research, a clinical research company, in general corporate and M&A matters
- BioSpecifics Technologies Corp., a Nasdaq-listed commercial-stage biopharmaceutical company, in its approximately $658 million sale to global specialty pharmaceutical company Endo International plc
- Reify Health, a provider of solutions empowering faster, predictable and more accessible clinical trials, in general corporate matters, including the company’s $220 million Series D round
- Replimune Group Inc., a biotechnology in general corporate matters, including capital markets transactions in excess of an aggregate of $1.1 billion in gross proceeds
- Takeda Pharmaceutical Company in its cross-border, multi-asset externalization transaction with Oak Hill Bio, under which Takeda received an upfront payment, an ownership stake in Oak Hill Bio, and potential milestones and royalty payments in exchange for six acquired and licensed programs
- uniQure N.V., a life sciences company in securities and numerous capital markets transactions
Sports Representations and Transactions
- Bolt Ventures in the acquisition and the subsequent sale of a controlling ownership interest in RSL Football Holdings
- Boston Unity Soccer Partners (BUSP) in its agreement to be awarded expansion rights for the National Women’s Soccer League’s 15th team
- Minority Investors in the acquisition of a non-controlling ownership interest in a Major League Baseball team
- Next 3 and Carolyn Tisch Blodgett, founder and CEO of Next 3, on behalf of the Tisch family, in its strategic investment in NJ/NY Gotham FC of the National Women’s Soccer League
- RSL Football Holdings in the negotiation of its expansion rights for the Utah Royal’s of the National Women’s Soccer League
- Unrivaled Sports, a U.S. leader in youth sports’ experiences, in connection with its formation, its $120 million funding round led by DICK’s Sporting Goods and numerous acquisitions
Technology Representations and Transactions
- 128 Technology, an artificial intelligence (AI) driven, software-defined wide area networks provider, in its $450 million sale to Juniper Networks
- Broadly Inc., a venture-backed startup helping businesses cultivate strong relationships across customer interactions, in the company’s acquisition by Vendasta
- HitPoint Studios and its spun-off real-money gaming business, LuckyPoint, in their sale to a subsidiary of PENN Entertainment, a leading provider of integrated entertainment, sports content, and casino gaming experiences
- PCTEL Inc., a leading global provider of wireless technology solutions, in connection with its sale to Amphenol Corporation
- Selina Hospitality PLC on its merger with BOA Acquisition Corp., a publicly traded SPAC, and various capital markets transactions
- Upskill, wearable technology provider, in its sale to TeamViewer, a connectivity technology company
- Yesware, a venture-backed start-up in connection with its sale to Vanedasta